Advertisement

Topics

The Institutes for Pharmaceutical Discovery, LLC Company Profile

12:43 EDT 24th June 2018 | BioPortfolio

The Institutes for Pharmaceutical Discovery, LLC (IPD) is a privately held company founded by James M. Nolan, President and CEO, and Gordon Polley, Chairman.IPD is managed by a cadre of experienced pharmaceutical executives, financial managers and dedicated senior scientists, all of whom have had extensive experience in pharmaceutical drug development. This group also oversees the vision and function of each individual institute it creates...

Location

23 Business Park Drive
Branford
Connecticut
06405
United States of America

Contact

Email: info@ipd-discovery.com


News Articles [1080 Associated News Articles listed on BioPortfolio]

New study explains how your brain helps you learn new skills

(Gladstone Institutes) Researchers from the Gladstone Institutes uncovered how a special type of neuron improves the efficiency of procedural learning. They initially wanted to show how the specialize...

International agreement that human-relevant research is needed to enhance drug discovery

(Humane Society International) Proceedings of a multistakeholder workshop co-organized by The Humane Society of the United States, Humane Society International and the National Institutes of Health un...

Label-free drug discovery solutions provider receives grant from NIH

Provider of label-free drug discovery solutions, SAMDI Tech, has announced it has received a small business innovation research (SBIR) grant from the National Institutes of Health (NIH)…

Beacon enters drug discovery collaboration with Janssen

US-based drug discovery firm Beacon Discovery has entered a multi-year collaboration agreement with Janssen Pharmaceuticals for small molecule compounds to...Read More... The post Beacon enters drug d...

InterMed Discovery: The World's Largest Natural Product Library

In this interview Fintan Walton talks to Mr Erik Metz, Head of Business Development at InterMed Discovery - a Natural Product lead discovery company from Dortmund, Germany. Erik Metz explains how Inte...

Visualising biologics discovery: dealing with complex data

The last few years have seen a huge push in biologics drug discovery, with over 200 approved drugs on the...Read More... The post Visualising biologics discovery: dealing with complex data appeared fi...

Beacon, the guiding light in antibody discovery? Another top 10 pharma signs up

Novartis will install Berkeley Lightsâ Beacon antibody discovery technology, the sixth large pharmaceutical firm to adopt the platform in less than a year.

UK builds world’s first fully automated drug discovery facility

The UK Government has announced a pioneering project to drive fast and effective drug discovery. Based at the new Rosalind...Read More... The post UK builds world’s first fully automated drug discov...

PubMed Articles [1044 Associated PubMed Articles listed on BioPortfolio]

Discovery and development of new antibacterial drugs: learning from experience?

Antibiotic (antibacterial) resistance is a serious global problem and the need for new treatments is urgent. The current antibiotic discovery model is not delivering new agents at a rate that is suffi...

Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processes.

The pharmaceutical 'QbD for R&D' needs extension of the established QbD model with elements such as unmet therapeutic need, stakeholder satisfaction, modern quality management tools, and reconsiderati...

Drug discovery, development and delivery in Alzheimer's disease.

The future of LC-MS for pharmaceutical analysis: an interview with Jun Qu.

Jun Qu speaks to Sankeetha Nadarajah, Editor of Bioanalysis: Jun Qu is the group leader of the proteomics and pharmaceutical analysis lab of SUNY-Buffalo (NY, USA) and a Professor in the Department of...

Using network-based expert engagement to advance pharmaceutical research and development.

Clinical Trials [618 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Companies [2608 Associated Companies listed on BioPortfolio]

The Institutes for Pharmaceutical Discovery, LLC

The Institutes for Pharmaceutical Discovery, LLC (IPD) is a privately held company founded by James M. Nolan, President and CEO, and Gordon Polley, Chairman.IPD is managed by a cadre of experienced ph...

Institute for Diabetes Discovery

The Institute for Diabetes Discovery, LLC, (IDD) is the largest privately-held biopharmaceutical company in the United States dedicated to the research and discovery of novel drugs and therapeutics fo...

Pyxis Discovery

Pyxis Discovery offers chemistry-based drug discovery services to the global pharmaceutical industry and develops products and services on the basis of computational chemistry. The activities of Pyxis...

Tularik Incorporated

We have developed a drug discovery and development infrastructure that we believe positions us to become a leading pharmaceutical company. Our drug discovery and development expertise includes molecul...

Affymax

Affymax, Inc. is a drug discovery powerhouse uniquely positioned to leverage over a decade of pharmaceutical drug discovery experience. As an industry pioneer with a five-year history working inside G...

More Information about "The Institutes for Pharmaceutical Discovery, LLC" on BioPortfolio

We have published hundreds of The Institutes for Pharmaceutical Discovery, LLC news stories on BioPortfolio along with dozens of The Institutes for Pharmaceutical Discovery, LLC Clinical Trials and PubMed Articles about The Institutes for Pharmaceutical Discovery, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Institutes for Pharmaceutical Discovery, LLC Companies in our database. You can also find out about relevant The Institutes for Pharmaceutical Discovery, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record